Matt Fazio

Matt Fazio is a seasoned marketing professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Director of HCP Marketing at Neurelis, Inc., Matt has also held roles as Senior Marketing Consultant and Director of Marketing for Rare Lymphomas, T-Cell Therapeutics, Hematology, SOT, and Cell and Gene Therapy at Atara Biotherapeutics. Additionally, Matt was involved in the GOCOVRI launch team at Adamas Pharmaceuticals, Inc., focusing on neuroscience marketing for movement disorders, and contributed to US neuroscience marketing for movement disorders at Impax Laboratories.